The Market Reports

Synopsis
The global market for Ibuprofen was estimated to be worth US$ 98 million in 2024 and is forecast to a readjusted size of US$ 118 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Ibuprofen cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
The ibuprofen market is driven largely by the sustained global demand for finished ibuprofen products, both over-the-counter and prescription-based. As ibuprofen remains one of the most widely used nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief, fever reduction, and anti-inflammatory applications, pharmaceutical manufacturers maintain strong demand for a steady supply of high-quality API. Additionally, the growing healthcare needs of emerging economies, especially in Asia-Pacific, Latin America, and parts of Africa, are expanding the customer base for generic drug production, further fueling API demand. Large-scale production efficiencies, ongoing investments in capacity expansion by major API producers (particularly in India and China), and the consistent use of ibuprofen in emergency relief supplies and public health programs also contribute significantly to market growth. Furthermore, the rising trend of contract manufacturing and outsourcing of API production by pharmaceutical companies to cost-effective regions is strengthening the global ibuprofen API supply chain.
However, the ibuprofen API market also faces several notable challenges. One of the biggest issues is the heavy concentration of production in a few countries, making the global supply vulnerable to disruptions, such as regulatory changes, environmental restrictions, or geopolitical tensions. Volatility in raw material prices, especially for petroleum-based intermediates used in ibuprofen synthesis, can also impact production costs and profit margins. Regulatory pressures are increasing globally, with stricter Good Manufacturing Practice (GMP) compliance requirements and environmental regulations adding to operational costs for API manufacturers. Additionally, the intense competition among generic API suppliers has led to price wars, eroding profitability and making it difficult for smaller players to survive without scale or specialization. Sustainability concerns, particularly regarding waste management and carbon footprint in large-scale chemical synthesis, are also beginning to influence buyer preferences, pushing the industry toward greener production technologies
This report aims to provide a comprehensive presentation of the global market for Ibuprofen, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ibuprofen by region & country, by Type, and by Application.
The Ibuprofen market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ibuprofen.
Market Segmentation
By Company
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Hisoar
Segment by Type
USP
EP
Segment by Application
Tablet
Capsule
Suspension
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ibuprofen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ibuprofen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ibuprofen in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index